Trial intelligence / Profile preview

AdimFlu-S (QIS) Immunogenicity and Safety in Healthy Children and Adolescents

NCT04101435Phase 3Completed

Sponsor
Adimmune
Start
Dec 2016
Primary completion
Jul 2017
Modality
Vaccines & Immunotherapeutics
01

Overview

A Phase 3 trial of influenza virus vaccine, split virion in influenza, sponsored by Adimmune. Started Dec 2016; status: completed.

02

Drugs

influenza virus vaccine, split virion
03

Conditions

influenza

Beyond the preview

Go deeper on NCT04101435.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04101435.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call